Clayton Silver Project Drill Core Samples

RNS Number : 2307O
Sunrise Resources Plc
08 February 2021
 

8 February 2021

 

 

SUNRISE RESOURCES PLC

("Sunrise" or "the Company")

 

 

Clayton Silver Project Drill Core Samples

 

Sunrise Resources plc has received a number of shareholder enquiries regarding the delay to the announcement of drill core assay results from the drill programme carried out at its Clayton Silver Project in November 2020.

 

The assay results have not yet been received by the Company and it has been advised by the independent laboratory carrying out the assay work that the laboratory is continuing to work through a large backlog of samples, as originally advised by the Company in its announcement of 9 November 2020, caused by the confluence of high demand for its services, and staff absenteeism due to Covid-19.

 

The laboratory has indicated that results may not be available to the Company before the end of this month.

 

The Company will release the results as soon as they become available as is its normal practice for all material assay, analytical and test results.

 

This announcement contains inside information as defined in Article 7 of EU Regulation 596/2014. 

 

 

Further information:

 

Sunrise Resources plc

Patrick Cheetham, Executive Chairman

Tel: +44 (0)1625 838 884

 

Beaumont Cornish Limited

Nominated Adviser

James Biddle/Roland Cornish

Tel: +44 (0)207 628 3396

 

Peterhouse Capital Limited

Broker

Lucy Williams/Duncan Vasey

 

Tel: +44 (0)207 469 0930

Shares in the Company trade on AIM. EPIC: "SRES". Website: www.sunriseresourcesplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DRLEAPAKEFXFEEA
UK 100

Latest directors dealings